+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Identification of epigenetic factors regulating the mesenchyme to epithelium transition by RNA interference screening in breast cancer cells



Identification of epigenetic factors regulating the mesenchyme to epithelium transition by RNA interference screening in breast cancer cells



Bmc Cancer 16: 700



In breast cancer, the epithelial to mesenchyme transition (EMT) is associated to tumour dissemination, drug resistance and high relapse risks. It is partly controlled by epigenetic modifications such as histone acetylation and methylation. The identification of genes involved in these reversible modifications represents an interesting therapeutic strategy to fight metastatic disease by inducing mesenchymal cell differentiation to an epithelial phenotype. We designed a siRNA library based on chromatin modification-related to functional domains and screened it in the mesenchymal breast cancer cell line MDA-MB-231. The mesenchyme to epithelium transition (MET) activation was studied by following human E-CADHERIN (E-CAD) induction, a specific MET marker, and cell morphology. Candidate genes were validated by studying the expression of several differential marker genes and their impact on cell migration. The screen led to the identification of 70 gene candidates among which some are described to be, directly or indirectly, involved in EMT like ZEB1, G9a, SMAD5 and SMARCD3. We also identified the DOT1L as involved in EMT regulation in MDA-MB-231. Moreover, for the first time, KAT5 gene was linked to the maintenance of the mesenchymal phenotype. A multi-parametric RNAi screening approach was developed to identify new EMT regulators such as KAT5 in the triple negative breast cancer cell line MDA-MB-231.

(PDF emailed within 0-6 h: $19.90)

Accession: 058039215

Download citation: RISBibTeXText

PMID: 27581651

DOI: 10.1186/s12885-016-2683-5


Related references

Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America 107(26): 11811-6, 2010

Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability. Oncotarget 7(2): 1796-1807, 2016

Role of epigenetic mechanisms in epithelial-to-mesenchymal transition of breast cancer cells. Translational Research 165(1): 126-142, 2015

MHP-1 inhibits cancer metastasis and restores topotecan sensitivity via regulating epithelial-mesenchymal transition and TGF-β signaling in human breast cancer cells. Phytomedicine 23(10): 1053-1063, 2017

Regulatory T Cells Promote β-Catenin--Mediated Epithelium-to-Mesenchyme Transition During Radiation-Induced Pulmonary Fibrosis. International Journal of Radiation Oncology, Biology, Physics 93(2): 425-435, 2015

Connexin43 repression following epithelium-to-mesenchyme transition in embryonal carcinoma cells requires Snail1 transcription factor. Differentiation; Research in Biological Diversity 75(3): 208-218, 2007

Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium. Bmc Cancer 15: 645, 2016

Kisspeptin-10 inhibits the migration of breast cancer cells by regulating epithelial-mesenchymal transition. Oncology Reports 33(2): 669-674, 2015

RNA Interference Screening to Identify Proliferation Determinants in Breast Cancer Cells. Bio-Protocol 7(15), 2017

Fibroblast growth factor 2 reactivates G1 checkpoint in SK-N-MC cells via regulation of p21, inhibitor of differentiation genes (Id1-3), and epithelium-mesenchyme transition-like events. Endocrinology 150(9): 4044-4055, 2009

Host Factors and Risk of Breast Cancer Recurrence: Genetic, Epigenetic and Biologic Factors and Breast Cancer Outcomes. Advances in Experimental Medicine and Biology 862: 143-153, 2015

miR-3646 promotes cell proliferation, migration, and invasion via regulating G2/M transition in human breast cancer cells. American Journal of Translational Research 8(4): 1659-1677, 2016

The tetraindole SK228 reverses the epithelial-to-mesenchymal transition of breast cancer cells by up-regulating members of the miR-200 family. Plos One 9(6): E101088, 2015

DNA methylation data for identification of epigenetic targets of resveratrol in triple negative breast cancer cells. Data in Brief 11: 169-182, 2017

Basal-luminal epithelial cell differentiation in prostate cancer is associated with epithelial-mesenchymal transition and epithelium migration in the mesenchyme. Urologiia 2017(5): 85-91, 2017